Retevmo 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26FCJ9Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,166
Award facts
- Contract value 100% obligated
- $16,165.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Retevmo 80 mg tablets (60-count units) under a firm fixed-price contract valued at $16,165.92. This delivery order, which represents a child contract under AmerisourceBergen's larger pharmaceutical prime vendor agreement with DLA, does not utilize a set-aside designation and was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 13, 2025. Retevmo is a specialized oncology medication, reflecting the breadth of pharmaceutical products supplied through the DLA Medical Supply Chain to support military and federal healthcare systems.
This award is executed under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of delivery orders covering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's federal contract awards demonstrate consistent capability to meet competitive procurement requirements and fulfill diverse medical supply needs for military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FCJ9Q?
SPE2DR26FCJ9Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DR26FCJ9Q worth?
The government has obligated $16,166 on SPE2DR26FCJ9Q.
Is contract SPE2DR26FCJ9Q an order under another contract?
Yes. SPE2DR26FCJ9Q is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCJ9Q competed?
The extent of competition for SPE2DR26FCJ9Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award